Banner Life Sciences
Banner Life Sciences is an entrepreneurial specialty pharmaceutical company dedicated to identifying unmet clinical needs and leveraging formulation expertise and proprietary technologies to develop medicines that improve patient lives. The company emphasizes innovation, scientific advancement, and high standards of quality and compliance to deliver safe and effective medicines.
Industries
Nr. of Employees
small (1-50)
Banner Life Sciences
3980 Premier Drive, Suite 110, High Point, North Carolina 27265
Patents
Products
Oral monomethyl fumarate formulation for relapsing multiple sclerosis (disease-modifying therapy)
An oral small-molecule disease-modifying therapy indicated for treatment of relapsing forms of multiple sclerosis; developed as an alternative formulation to established fumarate therapies to reduce relapse frequency and clinical disability progression.
Oral monomethyl fumarate formulation for relapsing multiple sclerosis (disease-modifying therapy)
An oral small-molecule disease-modifying therapy indicated for treatment of relapsing forms of multiple sclerosis; developed as an alternative formulation to established fumarate therapies to reduce relapse frequency and clinical disability progression.
Services
Application of formulation science and proprietary formulation technologies to develop differentiated pharmaceutical products targeting unmet clinical needs.
Design and execution of development strategies to pursue efficient regulatory approval pathways for pharmaceutical products.
Development and operationalization of U.S.-focused compliance programs including governance, written policies, training, monitoring, and remediation procedures.
Support for creating commercial opportunities through intellectual property protection and market-facing activities for specialty pharmaceuticals.
Application of formulation science and proprietary formulation technologies to develop differentiated pharmaceutical products targeting unmet clinical needs.
Design and execution of development strategies to pursue efficient regulatory approval pathways for pharmaceutical products.
Development and operationalization of U.S.-focused compliance programs including governance, written policies, training, monitoring, and remediation procedures.
Support for creating commercial opportunities through intellectual property protection and market-facing activities for specialty pharmaceuticals.
Expertise Areas
- Formulation development
- Specialty pharmaceutical development
- Regulatory strategy and submissions
- Compliance program implementation and governance
Key Technologies
- Proprietary formulation platforms
- Oral small-molecule formulation
- Regulatory submission frameworks
- Compliance program frameworks
News & Updates
Announcement of FDA approval for BAFIERTAM, a treatment for relapsing forms of MS.
Announcement of FDA approval for BAFIERTAM, a treatment for relapsing forms of MS.